Introduction to St. Jude Children's Research Hospital

Introduction to St. Jude Children’s Research Hospital
By Bridgette Schafer 

 

 

 

 

For the final month of 2020, Macrothink is very proud to have partnered with St. Jude Children’s Research Hospital. Founded in 1962 by renowned actor Danny Thomas, St. Jude has grown to be a world leader in treatment and research for pediatric disease.

 

St. Jude's campus in Memphis, Tennessee via the St. Jude website.

 

Every year around the world, 400,000 children are diagnosed with cancer, with 90% of these kids living in middle and low-income countries lacking adequate resources for treatment (St. Jude 2019 Annual Report). Furthermore, 1 in 5 children diagnosed with cancer in the United States will not live to see adulthood; in middle and low-income countries, 4 in 5 children will not survive (St. Jude Children's Research Hospital). In attempts to diminish the opportunity gap for children in poorer countries, St. Jude has donated more than $100 million to fund research and treatment globally. 

 

Photo from the St. Jude 2019 Annual Report of Jakayla, a little girl treated for Acute Lymphoblastic Leukemia, holding her preschool graduation certificate. 

 

In their mission to help as many children as possible, St. Jude treats around 8,600 patients annually from all 50 states and abroad. The hospital has 8 affiliate clinics in the U.S., and 24 partner sites in 17 countries worldwide. To assist their on-site patients, St. Jude built a school to allow kids to continue their educational pursuits in addition to offering therapy, babysitting, translation assistance, and more to aid the whole family. The hospital aims to create a sense of normalcy for their young patients, wanting them to be able to enjoy their childhoods to the utmost extent possible. We at Macrothink are especially moved by the artistic outlets the hospital enthusiastically provides for patients. 

 

Photo via the St. Jude 2019 Annual Report.

 

In order to keep up operations and continue vital research efforts, St. Jude uses $1 billion per year, the majority of which comes from independent donors. Because of the research St. Jude has completed over the decades and the treatments that have come from it, the rate of survival for childhood cancer has increased from 20% to 80%; the hospital admirably shares these findings freely throughout the world. Recently, research led to the 2019 discovery of a cure for Severe Combined Immunodeficiency (SCID), the most serious primary immunodeficiency disease (American Academy of Allergy Asthma & Immunology). St. Jude is currently building a new research center to pursue new treatments for pediatric cancers and diseases.

 

Omarion, a little boy born with SCID, is able to live out his childhood after being treated with St. Jude's groundbreaking approach. Photo via St. Jude's 2019 Annual Report. 

 

St. Jude Children’s Research Hospital determinedly strives to save as many children as possible, proudly instilling that “no child is denied treatment based on race, religion or a family's ability to pay,” (St. Jude Children's Research Hospital). From travel to treatment to food, every single cost families are faced with is covered by donations to St. Jude. Macrothink is so proud to have partnered with St. Jude, and our hearts are lifted by the monumental work this hospital continues to do in order to save children’s lives. 

 

Jakayla, grown up and embracing her mother, Lisa, and brother, Javon, both of whom were also treated at St. Jude for Acute Lymphoblastic Leukemia. Photo from the 2019 Annual Report. 

 



Sources:

https://www.cancer.org/cancer/cancer-in-children/key-statistics.html

https://www.stjude.org/content/dam/en_US/shared/www/about-st-jude/financial-information/alsac-stjude-annual-report-2019.pdf 

https://www.stjude.org/ 

https://www.aaaai.org/conditions-and-treatments/primary-immunodeficiency-disease/severe-combined-immunodeficiency